Andrea Redd

Andrea Redd serves as Associate Vice President, Global Regulatory Drug Delivery Devices at Eli Lilly, with 24+ years plus of pharmaceutical industry experience. With a career centered in CMC regulatory principles and product management, she transitioned to combination products in 2014, successfully bridging drug and device regulatory regulations. Her expertise spans CMC aspects of drug development for both generic and new drug (NDA and BLA) submissions.